Boston Bio Systems informs about outcome of board meeting

14 Nov 2024 Evaluate
Boston Bio Systems has informed that Board of directors of the company at its meeting held on Thursday, November 14, 2024, has considered and approved Standalone un-audited financial results of the company for the quarter and half year ended September 30, 2024. A copy of said results along with the Limited Review report of the Statutory Auditors is attached as ‘Annexure A’,

The above information is a part of company’s filings submitted to BSE.

Boston Commerce Share Price

7.27 0.00 (0.00%)
04-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Poly Medicure 1899.60
Laxmi Denta 269.50
Nureca Ltd. 305.20
Hemant Surgical Inds 294.60
Prevest Denpro 438.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×